| 000 | 00822 a2200241 4500 | ||
|---|---|---|---|
| 005 | 20250518020827.0 | ||
| 264 | 0 | _c20190128 | |
| 008 | 201901s 0 0 eng d | ||
| 022 | _a1533-4406 | ||
| 024 | 7 |
_a10.1056/NEJMc1815776 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aCollins, Francis S | |
| 245 | 0 | 0 |
_aThe Next Phase of Human Gene-Therapy Oversight. _h[electronic resource] |
| 260 |
_bThe New England journal of medicine _c01 2019 |
||
| 300 |
_a402 p. _bdigital |
||
| 500 | _aPublication Type: Letter; Comment | ||
| 650 | 0 | 4 | _aGenetic Therapy |
| 650 | 0 | 4 | _aGovernment Regulation |
| 650 | 0 | 4 | _aHumans |
| 700 | 1 | _aGottlieb, Scott | |
| 773 | 0 |
_tThe New England journal of medicine _gvol. 380 _gno. 4 _gp. 402 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1056/NEJMc1815776 _zAvailable from publisher's website |
| 999 |
_c29284032 _d29284032 |
||